Dixon Hubard Feinour & Brown Inc Abbott Laboratories Transaction History

Dixon Hubard Feinour & Brown Inc

$842 Million
Q2 2022

A detailed history of Dixon Hubard Feinour & Brown Inc transactions in Abbott Laboratories stock. As of the latest transaction made, Dixon Hubard Feinour & Brown Inc holds 80,910 shares of ABT stock, worth $9.26 Million. This represents 1.04% of its overall portfolio holdings.

Number of Shares

80,910

Previous 81,915 1.23%

Holding current value

$9.26 Million

Previous $9.7 Million 9.32%

% of portfolio

1.04%

Previous 0.97%

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Jul 22, 2022	SELL	$102.07 - $123.37 $102,580 - $123,986	-1,005 Reduced 1.23%	80,910 $8.79 Million
Q1 2022 May 09, 2022	SELL	$114.02 - $139.04 $65,789 - $80,226	-577 Reduced 0.7%	81,915 $9.7 Million
Q4 2021 Jan 10, 2022	BUY	$115.53 - $141.46 $1.68 Million - $2.05 Million	14,521 Added 21.36%	82,492 $11.6 Million
Q3 2021 Oct 19, 2021	SELL	$116.66 - $129.06 $8,982 - $9,937	-77 Reduced 0.11%	67,971 $8.03 Million
Q2 2021 Aug 23, 2021	SELL	$105.79 - $124.53 $7,299 - $8,592	-69 Reduced 0.1%	68,048 $7.89 Million
Q1 2021 May 14, 2021	SELL	$108.84 - $128.23 $112,105 - $132,076	-1,030 Reduced 1.49%	68,117 $8.16 Million
Q3 2020 Nov 12, 2020	BUY	$91.64 - $111.29 $112,992 - $137,220	1,233 Added 1.82%	69,147 $7.53 Million
Q2 2020 Jul 31, 2020	BUY	$76.57 - $98.0 $4.59 Million - $5.88 Million	59,950 Added 752.76%	67,914 $6.78 Million
Q4 2019 Feb 14, 2020	SELL	$78.51 - $87.4 $7,851 - $8,740	-100 Reduced 1.24%	7,964 $692,000
Q2 2019 Aug 14, 2019	SELL	$72.88 - $85.0 $72 - $85	-1 Reduced 0.01%	8,064 $678,000
Q1 2019 May 17, 2019	BUY	$66.22 - $80.06 $50,327 - $60,845	760 Added 10.4%	8,065 $645,000
Q4 2018 Feb 13, 2019	BUY	$65.56 - $74.27 $13,112 - $14,854	200 Added 2.81%	7,305 $528,000
Q3 2018 Nov 06, 2018	SELL	$60.81 - $73.36 $25,540 - $30,811	-420 Reduced 5.58%	7,105 $521,000
Q1 2018 May 14, 2018	SELL	$56.27 - $63.62 $75,964 - $85,887	-1,350 Reduced 15.21%	7,525 $451,000
Q4 2017 Feb 20, 2018	SELL	$53.68 - $57.47 $26,840 - $28,735	-500 Reduced 5.33%	8,875 $506,000
Q3 2017 Nov 08, 2017	BUY	$48.06 - $53.64 $450,562 - $502,875	9,375	9,375 $500,000

Others Institutions Holding ABT

# of Institutions

3,164

Shares Held

1.33B

Call Options Held

8.63M

Put Options Held

7.19M

View Full List

About ABBOTT LABORATORIES

Ticker ABT
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 1,751,219,968
Market Cap $200B
Description
Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...

More about ABT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Dixon Hubard Feinour & Brown Inc, based on Form 13F filings with the SEC.

News

Stay updated on Dixon Hubard Feinour & Brown Inc with notifications on news.

Account

Dixon Hubard Feinour & Brown Inc Abbott Laboratories Transaction History